810 related articles for article (PubMed ID: 10874024)
1. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
2. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
3. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
Chang KW; Lin SC; Koos S; Pather K; Solt D
Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
[TBL] [Abstract][Full Text] [Related]
4. Rapid in vivo assay for topical oral cancer chemopreventive agents.
Shabany K; Chiu PC; Raghian A; Chang KW; Solt DB
Int J Oncol; 2002 Jul; 21(1):159-64. PubMed ID: 12063563
[TBL] [Abstract][Full Text] [Related]
5. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
7. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
8. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.
Shahnavaz SA; Regezi JA; Bradley G; Dubé ID; Jordan RC
J Pathol; 2000 Mar; 190(4):417-22. PubMed ID: 10699989
[TBL] [Abstract][Full Text] [Related]
12. [Identification of telomerase activity in the experimental carcinogenesis of oral cavity].
Mao Z; Gao Z; Xu P; Zuo H; He Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Feb; 18(1):52-4, 57. PubMed ID: 12539365
[TBL] [Abstract][Full Text] [Related]
13. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
16. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.
Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G
Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
18. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
[TBL] [Abstract][Full Text] [Related]
19. [The role of P53 gene in the development of oral squamous cell carcinoma: study of P53 gene mutation by silver staining polymerase chain reaction-single strand conformation polymorphism].
Chen Q; Fu J; Yang G
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):337-40. PubMed ID: 9592286
[TBL] [Abstract][Full Text] [Related]
20. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]